Acute lymphangitis of right lower limb
ICD-10 L03.125 is a billable code used to indicate a diagnosis of acute lymphangitis of right lower limb.
Acute lymphangitis of the right lower limb is an inflammatory condition characterized by the infection of the lymphatic vessels, often resulting from bacterial infections, most commonly due to Streptococcus or Staphylococcus species. Clinically, patients may present with symptoms such as localized pain, swelling, erythema, and warmth along the affected limb, often accompanied by systemic symptoms like fever and malaise. The anatomy involved includes the superficial and deep lymphatic vessels of the right lower limb, which can become obstructed or inflamed due to the infection. Disease progression can lead to complications such as abscess formation or systemic infection if not treated promptly. Diagnostic considerations include a thorough clinical examination, history of recent skin injury or infection, and possibly imaging studies to assess lymphatic involvement. Laboratory tests may reveal leukocytosis and elevated inflammatory markers, supporting the diagnosis of acute lymphangitis.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L03.125 specifically covers acute lymphangitis of the right lower limb, which is characterized by inflammation of the lymphatic vessels due to infection. It is important to differentiate it from other skin infections such as cellulitis or abscesses.
L03.125 should be used when the clinical presentation specifically indicates acute lymphangitis affecting the right lower limb, as opposed to other conditions like cellulitis (L03.11) or lymphangitis of other limbs.
Documentation should include a detailed history of the patient's symptoms, physical examination findings, any relevant imaging studies, and treatment plans. Evidence of infection, such as laboratory results indicating elevated white blood cell counts, should also be included.
